DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALDMS - FR0012202497 - Common Stock
ALDMS.PA Key Statistics, Chart & Performance
The current stock price of ALDMS.PA is 1.31 EUR. In the past month the price increased by 0.38%. In the past year, price increased by 72.82%.
ALDMS.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 18.62 | 116.10B | ||
| 1MDT.MI | MEDTRONIC PLC | 18.68 | 114.29B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 17.92 | 48.32B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.36 | 23.31B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.39 | 23.36B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.67 | 23.11B | ||
| BIM.PA | BIOMERIEUX | 27.95 | 12.77B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 157.34 | 4.73B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 26.05 | 3.98B | ||
| DIA.MI | DIASORIN SPA | 18.66 | 3.46B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.93 | 1.32B | ||
| DRW8.DE | DRAEGERWERK AG | 9.67 | 1.17B |
Related stock screener links
About ALDMS.PA
Company Profile
Diagnostic Medical Systems engages in the development, design, and production of medical imaging systems. The company is headquartered in Gallargues-Le-Montueux, Occitanie and currently employs 152 full-time employees. The firm manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The firm operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
Company Info
DIAGNOSTIC MEDICAL SYSTEMS
9 Avenue du Canal Philippe
Gallargues-le-Montueux OCCITANIE FR
Employees: 129
Phone: 33467504900
DIAGNOSTIC MEDICAL SYSTEMS / ALDMS.PA FAQ
What does ALDMS do?
Diagnostic Medical Systems engages in the development, design, and production of medical imaging systems. The company is headquartered in Gallargues-Le-Montueux, Occitanie and currently employs 152 full-time employees. The firm manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The firm operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
What is the current price of ALDMS stock?
The current stock price of ALDMS.PA is 1.31 EUR. The price increased by 1.55% in the last trading session.
Does DIAGNOSTIC MEDICAL SYSTEMS pay dividends?
ALDMS.PA does not pay a dividend.
How is the ChartMill rating for DIAGNOSTIC MEDICAL SYSTEMS?
ALDMS.PA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) based on its PE ratio?
DIAGNOSTIC MEDICAL SYSTEMS (ALDMS.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
ALDMS.PA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ALDMS.PA. When comparing the yearly performance of all stocks, ALDMS.PA is one of the better performing stocks in the market, outperforming 92.23% of all stocks.
ALDMS.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALDMS.PA. ALDMS.PA may be in some trouble as it scores bad on both profitability and health.
ALDMS.PA Financial Highlights
Over the last trailing twelve months ALDMS.PA reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 40% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.34% | ||
| ROE | -22.44% | ||
| Debt/Equity | 0.9 |
ALDMS.PA Forecast & Estimates
10 analysts have analysed ALDMS.PA and the average price target is 2.2 EUR. This implies a price increase of 68.18% is expected in the next year compared to the current price of 1.31.